You could very well be right, nutriman. However, I think you would agree that the pps certainly is not going to go UP with non-approval from the FDA. At the very least there are a FEW investors who have actually bought in for the CLL approval. They will likely bow out with a negative response from the FDA.
Either way, I'm buying on FDA PR day. I'm chasing or I'm buying lower.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.